PGC 2025 Graphic
Course Agenda for 2025 Coming Soon

Annual Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation

About This Course:

The Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation is the longest-running professional development program in the biopharma space. Now in its 52nd year, this unique annual course prepares both new and experienced drug developers, regulators, policy makers, clinical investigators, and academic researchers for success in the life-sciences sector. Thousands of drug development professionals are alumni of this prestigious one-of-a-kind program. Top speakers from industry, academia, and the FDA share their expertise to create a highly stimulating and rewarding learning environment. For a complete list of topics and speakers, download the course brochure below.

The goal of the course is to provide a comprehensive overview of the pharmaceutical development process, focusing on topics vital to professionals involved in all aspects of bioinnovation. Participants include individuals employed by pharmaceutical and biotechnology companies, regulatory agencies, academic institutions, government entities, outsourcing providers, consultancies, investment firms, and other biopharmaceutical organizations involved in the research, development, regulation, and marketing of pharmaceutical products.



Educational Objectives

Clinical Pharmacology:  Integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.

Drug Development & Clinical Trials: Using a case-study approach, identify and solve practical, theoretical, and technical problems in human drug studies and analyze an experimental design for a new drug candidate.

Regulation: Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the U.S., Europe, Japan & other pharmaceutical markets.

 

Course Dates

January 30th, February 6th, 13th & 20th | 11 am - 3 pm EST | Online Synchronous

PGC Dates_Jan 2025
PGC Dates_Feb 2025

Who Should Attend?

  • Professionals working in or with the research-based biopharmaceutical industry

  • Physicians, clinical investigators, pharmacists, nurses, and academic researchers
  • Regulators and other government agencies involved in drug development
  • Outsourcing providers, consultants, investors, and analysts

Earn a Digital Course Completion Badge & Certificate!

  • Showcase the knowledge and skills you acquired from the program.
  • Share your learning achievements with clients, employers, and colleagues on online platforms and social media networks like LinkedIn, Facebook and Twitter.
"Taking the Tufts course was a tremendously beneficial experience for me. I'm so grateful to have learned so much and met such wonderful colleagues. You created a fantastic roster of speakers and presentations." Past Participant
“Being new to the industry I appreciated that all the presentations provided excellent background information before examining each topic in more depth.” Past Participant
“The Regulation overview for U.S., E.U., Japan, and China were extremely useful. The presentation captured essential knowledge for those areas.” Past Participant
“The mock drug groups activity was very helpful because it brought together a handful of people from different backgrounds and professions. It encouraged team-building and communication — two things that are very much needed in the work field.” Past Participant

 

 

Regular Rate

$2,750

 

 

Circle of Supporters Member Rate

(No end date)

$2,450

 

Academic/Non-Profit/Gov't

(No end date)

$2,450

The post graduate program typically receives 125 - 150 participants. Many companies choose to send multiple staff to participate in the program under a special, discounted registration rate.  If you would like to learn more about registering a group, please contact Sarah Wrobel


GET MORE INFORMATION

Have any questions? Enter your information below to get in touch with our enrollment team.